Signet Healthcare Partners — 2021 Investments
2 investments dated 2021 · listed companies and verified rows first · show all
Cerium Pharmaceuticals is a clinical-stage biopharmaceutical company developing therapies for rare kidney diseases, with a lead program (SNP-ACTH (1-39) Gel) targeting Primary Membranous Nephropathy (PMN).
BiotechHealthtechGaithersburg, US
Gregg Lapointe(Executive Officer, Director)Gregg A. Lapointe(Executive Officer, Director)Peter Collum(Director)Steve Eskenazi(Director)Robert Rubin(Director)Tom DePasquale(Director)
Board seatJames Gale· per SEC Form D · $10.1M raise · filed Jul 2021
Hologic develops medical technologies for women's health that detect, diagnose and treat health conditions across multiple countries.
FemTechHealthtechMedical DevicesRedwood City, US
Ken Haas(Director)Karen Talmadge(Director)Doug Fisher(Director)Christopher Owens(Executive Officer, Director)Chandra P. Leo(Director)
BoardJonathan MacQuitty(Director)
Board seatJoyce Erony· per SEC Form D · $50M raise · filed Dec 2021
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.